Learning Objectives On completing this program, participants will be able to: Give an overview of the epidemiology and pathogenesis of nonmelanoma skin cancer (NMSC) in organ transplant recipients Describe the presenting features and natural history of common skin cancers Identify risk factors for NMSC in organ transplant recipients Describe appropriate therapies for managing NMSC in organ transplant recipients, including oral retinoids Recognize possible adverse effects and drug interactions resulting from NMSC preventive therapies Understand the common adverse effects (AEs) of systemic retinoid chemoprevention and their prevention and management
